The Patent Finder

Daiichi Asubio Pharma Co., Ltd.

Also on record
Records under this name other than patents Daiichi Asubio Pharma Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Daiichi Asubio Pharma Co., Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,361,759Method for Producing L-Biopterin
Formerly held
Term ended
Term ended Apr 24, 2025 · High confidence
Term endedTerm ended Apr 24, 2025High confidence
US 8,367,623Glycolipid and medicine for autoimmune disease containing the same as active ingredient
Formerly held
Lapsed on the fee record
Ended Feb 5, 2025 · USPTO record
Lapsed on the fee recordEnded Feb 5, 2025USPTO record
US 7,732,583Glycolipids and synthetic method thereof as well as their synthetic intermediates, and synthetic intermediates, and synthetic method thereof
Formerly held
Term ended
Term ended Aug 8, 2024 · USPTO record
Term endedTerm ended Aug 8, 2024USPTO record
US 7,459,551Method for Preparing Cyclic Compounds
Formerly held
Term ended
Term ended Mar 25, 2024 · High confidence
Term endedTerm ended Mar 25, 2024High confidence
US 8,440,628Medical Compositions Containing Ghrelin
Formerly held
Term ended
Term ended Sep 17, 2023 · Medium confidence
Term endedTerm ended Sep 17, 2023Medium confidence
US 7,268,1281,3,5-Trisubstituted-5-Phenyl and 5-Pyridyl Pyrazolopyrimidinone Derivatives Having PDE7 Inhibiting Action
Formerly held
Term ended
Term ended Aug 3, 2023 · High confidence
Term endedTerm ended Aug 3, 2023High confidence
US 8,518,893Medical Compositions Containing Ghrelin
Formerly held
Term ended
Term ended May 21, 2023 · Medium confidence
Term endedTerm ended May 21, 2023Medium confidence
US 7,138,489Method for Producing a Modified Peptide
Formerly held
Term ended
Term ended Apr 10, 2023 · High confidence
Term endedTerm ended Apr 10, 2023High confidence
US 8,623,649A Method of Selecting a Cardiomyoctye Using Intracellular Mitochondria as an Indicator
Formerly held
Lapsed on the fee record
Ended Jan 7, 2022 · High confidence
Lapsed on the fee recordEnded Jan 7, 2022High confidence
US 7,026,293Treatment or Prophylaxis of Ischemic Heart Disease
Formerly held
Term ended
Term ended Aug 19, 2021 · High confidence
Term endedTerm ended Aug 19, 2021High confidence
10 of 119 patents shown.
Pro members see all 119.
Pro members: see all 119 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited